Please login to the form below
Autoimmune disorders
This page shows the latest Autoimmune disorders news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
Despite PPI dysfunction being implicated in a broad range of diseases, including cancer, fibrosis and autoimmune disorders, only a small proportion of PPIs are targeted by approved drugs. ... Earlier this month, the company exercised its option to
Latest news
-
Scleroderma Research Foundation launches clinical trial platform to advance treatments
The Scleroderma Research Foundation (SRF) has announced the launch of a new clinical trial platform aimed at advancing treatments for the rare autoimmune disease of the skin and organs. ... Using a model created over a decade ago to accelerate oncology
-
Gilead and EVOQ Therapeutics partner in deal potentially worth over $650m
There are more than 100 chronic autoimmune diseases, many of which are severely debilitating, and some life-threatening. ... EVOQ also partnered with Amgen in January 2021 to discover and develop novel drugs for autoimmune disorders.
-
Sanofi’s Enjaymo receives EC approval for rare autoimmune haemolytic anaemia
Enjaymo is currently the only approved treatment for CAD, a rare type of autoimmune haemolytic anaemia where part of the body’s immune system mistakenly destroys healthy red blood cells. ... and other autoimmune disorders,” said Professor Alexander
-
Amgen completes acquisition of ChemoCentryx in deal worth $3.7bn
ChemoCentryx is a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ... for severe active ANCA-associated vasculitis, an autoimmune disease for which there remains
-
Amgen to acquire ChemoCentryx in $3.7bn cash deal
ChemoCentryx is a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ... an umbrella term for a group of multi-system autoimmune diseases with small vessel inflammation
More from news
Approximately 4 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
Sanofi. Exclusive worldwide licence. INX-021, a pc CD40L mAb in autoimmune disorders.
-
Deal Watch November 2016
autoimmune disorders, such as rheumatoid arthritis. ... acquisition - company. 235. Idera Pharmaceuticals/ Vivelix Pharmaceuticals. IMO-9200, antagonist of TLR 7, 8 and 9, for non-malignant GI disorders (p1) back ups.
-
Deal Watch September 2016
as well as other autoimmune disorders plus VTP-38543 for atopic dermatitis. ... 210. Ligand / Seelos. Licence. 4 programmes including aplindore for CNS disorders.
-
Reaching new heights
Disease treatments in 2020 will be transformed by the increased number and quality of new drugs in clusters of innovation around cancer, hepatitis C, autoimmune disorders, heart disease and an array
-
Deal Watch March 2016
Padlock's technology targets autoimmune disorders with protein/peptidyl arginine deiminase (PAD) inhibitors and offers the potential to prevent disease development in patients with early stage disease. ... Acquisition - company. $600. Boehringer Ingelheim
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Former FDA adviser joins Precision for Medicine
Prior to her time with the FDA, Dr Seyfert-Margolis was chief science officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.
-
Questcor appoints SVP corporate strategic development
His main responsibilities will include identifying potential partnerships and acquisitions for the company, which specialises in developing treatments for difficult-to-treat autoimmune and inflammatory disorders.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Porterhouse Medical Group strengthens its leadership team in the US
Julia has worked in research, editorial, strategy, client service and business development across a range of therapy areas including multiple rare diseases, neuroscience, autoimmune and renal disorders.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
